Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 1.8B | 2.0B | 2.1B |
Cost of revenue | 1.2B | 1.2B | 1.3B | 1.3B |
Gross profit | 644M | 636M | 725M | 785M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 358M | 345M | 368M | 388M |
Other operating expenses | — | — | — | — |
Operating income | 286M | 291M | 357M | 397M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 26M | 24M | 25M | 26M |
Other income expense | -7M | -8M | -85M | -5M |
Pretax income | 254M | 258M | 248M | 366M |
Tax provision | 56M | 65M | 68M | 94M |
Net income | 198M | 193M | 180M | 272M |
Basic EPS | 0.9 | 0.9 | 0.8 | 1.2 |
Diluted EPS | 0.9 | 0.9 | 0.8 | 1.2 |
Basic average shares | 212M | 212.5M | 215.7M | 219M |
Diluted average shares | 213M | 215M | 218M | 220M |
EBITDA | 280M | 282M | 273M | 392M |
Net income from continuing op. | 262M | -83M | 309M | 334M |
Minority interests | -12M | -11M | -13M | -14M |
Preferred stock dividends | 0 | 0 | 0 | 0 |